BLMN three-lens brief
Evidence-based stock research on BLMN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +3.02% yesterday. · Debt-to-equity of 455% — balance-sheet-heavy.
- Moved +3.02% yesterday.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Outperforming SPY by 32.4pp over 30 days.
- P/E of 11.6 — trading at a value multiple.
- Analyst mean target $12.03 — 18% above current (10 analysts).
BLMN closed at $10.23 (+3.02%) as of 2026-11-12. Market cap: $877.25M. P/E (trailing) 11.6. Price is above the 50-day MA and above the 200-day MA. Positives: moved +3.02% yesterday.; 50-day MA above 200-day MA (golden-cross regime); price above both.. Concerns: debt-to-equity of 455% — balance-sheet-heavy.. Last quarter: Revenue $944.35M, net income -$2.18M, free cash flow $258.67M.
Why three lenses on BLMN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BLMN across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/BLMN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BLMN brief"></iframe>